Talquetamab
RxNorm 2644447
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2644447 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: talquetamab.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Talquetamab
(Atom ID: 12827130)
PTPrescribable
Designated preferred name (PT):
Talquetamab
(Atom ID: 12992318)
FNPrescribable
Full form of descriptor (FN):
Talquetamab (substance)
(Atom ID: 12992319)
Patient Education
Talquetamab-tgvs
Talquetamab-tgvs is used to treat multiple myeloma (a type of cancer of the bone marrow) that has returned or that did not respond to at least 4 other treatments. Talquetamab-tgvs is in a class of medications called bispecific T-cell engager antibodies. It works by killing cancer cells.
[Learn More]
* Please review the disclaimer below.